The Phase 1/2 trial is a first-in-human, open-label, multi-national study designed to evaluate the safety, tolerability, and efficacy of TSRA-196 in adults with AATD. Trial participants will receive a ...

U.S. nuclear power is seeing a resurgence as utilities, tech companies, and federal programs invest in restarts, SMRs, and next-generation reactors to meet growing demand and ... Wildfire risk ...

What's CODE SWITCH? It's the fearless conversations about race that you've been waiting for. Hosted by journalists of color, our podcast tackles the subject of race with empathy and humor. We explore ...